Merck Will Share Formula for its Covid Pill With Poor Countries

The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.

source https://www.nytimes.com/2021/10/27/health/covid-pill-access-molnupiravir.html